{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:12:40Z","timestamp":1770768760381,"version":"3.50.0"},"reference-count":18,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.1182\/bloodadvances.2025017817","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T19:55:05Z","timestamp":1762804505000},"page":"661-664","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Smoldering multiple myeloma in the United States: a population-based analysis"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-5784","authenticated-orcid":false,"given":"Shi-Yi","family":"Wang","sequence":"first","affiliation":[{"name":"1Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT"},{"name":"2Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-4174","authenticated-orcid":false,"given":"Rong","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT"},{"name":"2Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-5553","authenticated-orcid":false,"given":"Martin","family":"Schoen","sequence":"additional","affiliation":[{"name":"3Division of Hematology and Oncology, St. Louis University School of Medicine, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Huber","sequence":"additional","affiliation":[{"name":"4Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Feuer","sequence":"additional","affiliation":[{"name":"5Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Ruhl","sequence":"additional","affiliation":[{"name":"5Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-077X","authenticated-orcid":false,"given":"Natalia","family":"Neparidze","sequence":"additional","affiliation":[{"name":"2Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, CT"},{"name":"6Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9472-8032","authenticated-orcid":false,"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[{"name":"1Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT"},{"name":"2Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-9249","authenticated-orcid":false,"given":"Amy J.","family":"Davidoff","sequence":"additional","affiliation":[{"name":"5Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-9556","authenticated-orcid":false,"given":"Su-Hsin","family":"Chang","sequence":"additional","affiliation":[{"name":"4Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"12","key":"2026021015521968000_bib1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"25","key":"2026021015521968000_bib2","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"2026021015521968000_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00089","article-title":"Development of an algorithm to distinguish smoldering versus symptomatic multiple myeloma in claims-based data sets","volume":"1","author":"Fiala","year":"2017","journal-title":"JCO Clin Cancer Inform"},{"issue":"3","key":"2026021015521968000_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clml.2014.09.004","article-title":"Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis","volume":"15","author":"Go","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"2026021015521968000_bib5","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1038\/bcj.2016.100","article-title":"Prevalence, incidence and survival of smoldering multiple myeloma in the United States","volume":"6","author":"Ravindran","year":"2016","journal-title":"Blood Cancer J"},{"issue":"3","key":"2026021015521968000_bib6","doi-asserted-by":"crossref","first-page":"e6915","DOI":"10.1002\/cam4.6915","article-title":"Racial differences in treatment and survival among older patients with multiple myeloma","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med"},{"issue":"3","key":"2026021015521968000_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clml.2018.01.005","article-title":"Undertreatment of older patients with newly diagnosed multiple myeloma in the era of novel therapies","volume":"18","author":"Fakhri","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"18","key":"2026021015521968000_bib8","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1056\/NEJMc1310911","article-title":"Treatment for high-risk smoldering myeloma","volume":"369","author":"Kristinsson","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2026021015521968000_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ejh.12728","article-title":"Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study","volume":"97","author":"S\u00f8rrig","year":"2016","journal-title":"Eur J Haematol"},{"key":"2026021015521968000_bib10","unstructured":"National Cancer Institute\n          . Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2020 Census Data). Accessed 16 April 2025. https:\/\/seer.cancer.gov\/registries\/data.html."},{"key":"2026021015521968000_bib11","unstructured":"National Cancer Institute\n          . SEER Data Change History. Accessed 16 April 2025. https:\/\/seer.cancer.gov\/data\/data-changes.html."},{"key":"2026021015521968000_bib12","unstructured":"National Cancer Institute\n          . Site-Specific Data Item Recodes. Accessed 27 April 2025. https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/ssdi\/."},{"key":"2026021015521968000_bib13","unstructured":"National Cancer Institute\n          . EOD Data Version 3.2; Schema Discriminator 1: Multiple Myeloma Terminology. Accessed 27 April 2025. https:\/\/staging.seer.cancer.gov\/eod_public\/input\/3.2\/plasma_cell_myeloma\/discriminator_1\/?breadcrumbs=(\u223cview_schema\u223c,\u223cplasma_cell_myeloma\u223c."},{"key":"2026021015521968000_bib14","unstructured":"National Cancer Institute\n          . Cancer Incidence Rates Adjusted for Reporting Delay. Accessed 27 April 2025. https:\/\/surveillance.cancer.gov\/delay\/."},{"key":"2026021015521968000_bib15","unstructured":"National Cancer Institute\n          . Impact of COVID-19 on SEER Data Releases. Accessed 27 April 2024. https:\/\/seer.cancer.gov\/data\/covid-impact.html."},{"issue":"2","key":"2026021015521968000_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/10428194.2017.1334124","article-title":"Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer","volume":"59","author":"Muchtar","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"10345","key":"2026021015521968000_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0140-6736(22)00876-5","article-title":"Life expectancy by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities","volume":"400","author":"GBD US Health Disparities Collaborators","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"2026021015521968000_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41591-022-02183-6","article-title":"Prevalence of smoldering multiple myeloma based on nationwide screening","volume":"29","author":"Thorsteinsd\u00f3ttir","year":"2023","journal-title":"Nat Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/661\/2501446\/blooda_adv-2025-017817-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/661\/2501446\/blooda_adv-2025-017817-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:52:29Z","timestamp":1770756749000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/3\/661\/548130\/Smoldering-multiple-myeloma-in-the-United-States-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017817","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,10]]},"published":{"date-parts":[[2026,1,29]]}}}